⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1307930 | 0.82 | TSHR (0.35) | — | |
| SCHEMBL83531 | 0.77 | — | — | |
| SCHEMBL890533 | 0.77 | — | — | |
| SCHEMBL83373 | 0.75 | — | — | |
| SCHEMBL26436662 | 0.74 | — | — | |
| SCHEMBL4400624 | 0.74 | — | — | |
| SCHEMBL1524551 | 0.74 | — | — | |
| SCHEMBL17666415 | 0.74 | — | — | |
| SCHEMBL15065475 | 0.72 | TSHR (0.36) | — | |
| SCHEMBL15027382 | 0.72 | TSHR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2244575-A1 | ANGIOTENSIN II RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009094242-A1 | ANGIOTENSIN II RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2009-07-30 | — | — | WO | disclosed |